SentinelOne (S) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

PTC Therapeutics (PTCT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Bio-Techne faces significant macro and policy headwinds, including reduced academic research funding, China risks, and U.S.

Immix Biopharma, Inc. (IMMX) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting ...

Aeva Technologies, Inc. (AEVA) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces ...

But the decision today (6 June) could reverse this ban, as long as the crypto ETN is traded on an FCA-approved investment ...

What began as Elon Musk's embrace of right-wing populism has become a defining — and potentially harmful — chapter in his ...

Companies must be held accountable for their depredations before the next scramble for the continent under the guise of a ...

Discover the Coal India Stock Liveblog, your go-to destination for real-time updates and comprehensive analysis of a ...

Welcome to the Tata Steel Stock Liveblog, your real-time source for the latest updates and comprehensive analysis on a ...

The U.S. stock rebound has driven key indexes to the cusp of record levels, with fresh economic data and trade and fiscal ...